Researchers at Fox Chase Cancer Center in Philadelphia analyzed data from HIV+ patients diagnosed with lymphoma, collected over 17 years, to better understand how Hepatitis C virus (HCV) infection influences survival outcomes. Study leader Stefan K. Barta, MD, MS, MRCP presented the group’s findings at the 50th Annual Meeting of the American Society of Clinical Oncology in June 2014 in Chicago.